Apricus Wealth, LLC Abb Vie Inc. Transaction History

Apricus Wealth, LLC

$150 Million
Q3 2024

A detailed history of Apricus Wealth, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Apricus Wealth, LLC holds 19,370 shares of ABBV stock, worth $3.4 Million. This represents 2.56% of its overall portfolio holdings.

Number of Shares

19,370

Previous 19,165 1.07%

Holding current value

$3.4 Million

Previous $3.29 Million 16.37%

% of portfolio

2.56%

Previous 2.39%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$163.84 - $199.33 $33,587 - $40,862	205 Added 1.07%	19,370 $3.83 Million
Q2 2024 Jul 25, 2024	SELL	$154.79 - $180.76 $21,206 - $24,764	-137 Reduced 0.71%	19,165 $3.29 Million
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $160,619 - $183,010	-1,005 Reduced 4.95%	19,302 $3.51 Million
Q4 2023 Jan 22, 2024	SELL	$137.6 - $154.97 $31,648 - $35,643	-230 Reduced 1.12%	20,307 $3.15 Million
Q3 2023 Oct 24, 2023	BUY	$133.59 - $154.65 $62,787 - $72,685	470 Added 2.34%	20,537 $3.06 Million
Q2 2023 Jul 20, 2023	SELL	$132.51 - $164.9 $176,900 - $220,141	-1,335 Reduced 6.24%	20,067 $2.7 Million
Q1 2023 May 01, 2023	BUY	$144.61 - $166.54 $41,069 - $47,297	284 Added 1.34%	21,402 $3.41 Million
Q4 2022 Jan 31, 2023	SELL	$138.31 - $165.87 $22,682 - $27,202	-164 Reduced 0.77%	21,118 $3.41 Million
Q3 2022 Oct 31, 2022	BUY	$134.21 - $153.93 $29,526 - $33,864	220 Added 1.04%	21,282 $2.86 Million
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $138,308 - $175,834	-1,005 Reduced 4.55%	21,062 $3.23 Million
Q1 2022 Apr 21, 2022	SELL	$131.98 - $163.75 $270,559 - $335,687	-2,050 Reduced 8.5%	22,067 $3.46 Million
Q4 2021 Mar 09, 2022	BUY	$107.43 - $135.93 $2.59 Million - $3.28 Million	24,117 New	24,117 $3.27 Million

Others Institutions Holding ABBV

# of Institutions

3,852

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Apricus Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apricus Wealth, LLC with notifications on news.

Account

Apricus Wealth, LLC Abb Vie Inc. Transaction History